GlassScriptPhysician profile
Manisha Jakkidi
NPI 1083098925
$6,617.91
in general payments reported to CMS, 2019-2025
30 companies · $1,966 in 2025
The $1,966 reported for 2025 was more than what 78% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $406 · 2022: $1,840 · 2023: $1,323 · 2024: $1,083 · 2025: $1,966.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,689 · Travel and Lodging: $565 · Education: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,688.53 |
| Travel and Lodging | $565.27 |
| Education | $118.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,069.74 | 2021-2025 | |
| Boston Scientific Corporation | $1,383.02 | 2022-2025 | Overstitch Endoscopic Suturing System, Apollo Esg Nxt System, Epic Biliary |
| Janssen Biotech, INC. | $604.05 | 2022-2025 | Tremfya, Stelara, Remicade |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $429.18 | 2021-2025 | Xifaxan, Trulance, Relistor |
| Genzyme Corporation | $416.62 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $345.95 | 2021-2025 | Entyvio |
| Gilead Sciences, INC. | $168.80 | 2021-2023 | |
| Pfizer INC. | $138.96 | 2023-2025 | |
| Intercept Pharmaceuticals, INC. | $113.79 | 2021-2024 | Ocaliva |
| Madrigal Pharmaceuticals | $106.43 | 2024-2025 | Rezdiffra |
| Celgene Corporation | $102.53 | 2022-2024 | Zeposia |
| Evoke Pharma, INC. | $82.98 | 2022-2024 | Gimoti |
| Ardelyx, INC. | $76.19 | 2023-2024 | Ibsrela |
| Enterra Medical, INC. | $74.78 | 2025 | |
| Pentax of America, INC. | $68.92 | 2023-2024 | Pentax Medical, C2 Cryoballoon, Inspira |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $68.62 | 2022-2023 | Linzess |
| Conmed Corporation | $41.02 | 2025 | Conmed Biliary |
| Redhill Biopharma INC. | $40.54 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $38.76 | 2022-2023 | Dupixent |
| Merck Sharp & Dohme LLC | $38.02 | 2022-2023 | Dificid |
| Nestle Healthcare Nutrition INC. | $34.47 | 2022-2023 | |
| Intra-Sana Laboratories | $22.51 | 2021 | |
| Lilly USA, LLC | $20.88 | 2025 | Omvoh |
| Phathom Pharmaceuticals, INC. | $19.80 | 2024 | Voquezna |
| Celltrion USA INC. | $19.74 | 2024 | Zymfentra |
| Biocon Biologics INC | $19.69 | 2025 | Yesintek |
| Mylan Institutional INC. | $19.61 | 2023 | |
| Ferring Pharmaceuticals INC. | $19.04 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $17.50 | 2023 | Bylvay |
| Fresenius Kabi USA, LLC | $15.77 | 2024 | Idacio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manisha Jakkidi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.